Dosage and administration
Usage: Twist off the bottle cap and take it directly; Take it twice a day; Do not overdose.
Usage: Twist off the bottle cap and take it directly; Take it twice a day; Do not overdose.
Storage: This product should be stored in a cool, dry, dark place with the temperature of 16℃-27℃ and the humidity ≤ 50%.
ginsenoside 23%
Indications: This drug is indicated for cancer patients, people with a family history of cancer, or people exposed to work with radioactivity.
Product Benefits: This product can inhibit the activity of telomerase, thus preventing the proliferation and growth of tumor cells;
This product should not be used in combination with antibiotics;
This product should not be used in patients who are allergic to any component of this product;
Precautions: Combined use with other drugs or increased exposure to this product may result in clinically significant adverse reactions. Combined use with other drugs may significantly decrease the concentration of this product, leading to decreased therapeutic effect of the drug combination.
If there is any discomfort during use, please discontinue this product.
If the patient has any underlying medical condition, please consult the doctor before taking this product.
Please keep this product away from children. If the child accidentally ingests this product, please seek medical help immediately.
Usage: Twist off the bottle cap and take it directly; Take it twice a day; Do not overdose.
Storage: This product should be stored in a cool, dry, dark place with the temperature of 16℃-27℃ and the humidity ≤ 50%.
EGCG Sulforaphane cordycepin Ergothioneine Selenium Sodium benzoate
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84429-002 | 84429-002-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SELENIUM | H6241UJ22B | IACT |
| CORDYCEPIN | GZ8VF4M2J8 | IACT |
| GINSENOSIDES | 3K198YD54P | ACTIB |
| SULFORAPHANE | GA49J4310U | IACT |
| ERGOTHIONEINE | BDZ3DQM98W | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| EPIGALLOCATECHIN GALLATE | BQM438CTEL | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 496a0200-4d3a-cde3-e063-6294a90a897f | 1b4daf1d-a7a5-8fd1-e063-6294a90a817e | 2026-01-27 | Warnings | 1b4daf1d-a7a5-8fd1-e063-6294a90a817e |
Adverse event summaries are temporarily unavailable. Other product information remains available.